Page 59 - BH-3-3

Brain & Heart A left atrial appendage occlusion review

in canine model. Circulation. 2002;105(18):2217-2222. in challenging septa: A randomized comparison to
doi: 10.1161/01.cir.0000015605.30810.51 conventional technique. Biomed Res Int. 2017;2017:2351925.
45. Omran H, Tzikas A, Sievert H, Stock F. A history of doi: 10.1155/2017/2351925
percutaneous left atrial appendage occlusion with the 56. Zuercher R, Herling A, Schmidt MT, et al. Transesophageal
PLAATO device. Interv Cardiol Clin. 2018;7(2):137-142. echocardiography-guided transseptal left atrial access to
doi: 10.1016/j.iccl.2017.12.009 improve safety in patients undergoing pulmonary vein
isolation. J Clin Med. 2022;11(9):2546.
46. Chen S, Chun KRJ, Bordignon S, et al. Left atrial appendage
occlusion using LAmbre Amulet and Watchman in atrial doi: 10.3390/jcm11092546
fibrillation. J Cardiol. 2019;73(4):299-306. 57. Gowda ST, Qureshi AM, Turner D, et al. Transseptal
doi: 10.1016/j.jjcc.2018.10.010 puncture using surgical electrocautery in children and
adults with and without complex congenital heart disease.
47. Najim M, Reda Mostafa M, Eid MM, et al. Efficacy and safety Catheter Cardiovasc Interv. 2017;90(3):E46-E54.
of the new generation Watchman FLX device compared to
the Watchman 2.5: A systematic review and meta-analysis. doi: 10.1002/ccd.27202
Am J Cardiovasc Dis. 2023;13(5):291-299. 58. Zakka K, Erridge S, Chidambaram S, et al. Electrocautery,
48. Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer amulet diathermy, and surgical energy devices: Are surgical
left atrial appendage occluder versus watchman device for teams at risk during the COVID-19 pandemic? Ann Surg.
stroke prophylaxis (Amulet IDE): A randomized, controlled 2020;272(3):e257-e262.
trial. Circulation. 2021;144(19):1543-1552.
doi: 10.1097/SLA.0000000000004112
doi: 10.1161/CIRCULATIONAHA.121.057063
59. Perrotta L, Bordignon S, Dugo D, et al. Complications from
49. Jaiswal V, Ang SP, Shrestha AB, et al. Amplatzer amulet left atrial appendage exclusion devices. J Atr Fibrillation.
versus watchman device for percutaneous left atrial 2014;7(1):1034.
appendage closure: A systematic review and meta-analysis.
Medicine (Baltimore). 2023;102(26):e34185. doi: 10.4022/jafib.1034
doi: 10.1097/MD.0000000000034185 60. Raphael CE, Friedman PA, Saw J, Pislaru SV, Munger TM,
Holmes DR. Residual leaks following percutaneous left
50. Jin LS, Ke JY, Lin YN, et al. Percutaneous left atrial atrial appendage occlusion: Assessment and management
appendage closure using the LAmbre device in patients with implications. EuroIntervention. 2017;13:1218-1225.
atrial fibrillation and left atrial appendage thrombus. Front
Cardiovasc Med. 2022;9:1071119. doi: 10.4244/EIJ-D-17-00469
doi: 10.3389/fcvm.2022.1071119 61. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical
impact of incomplete left atrial appendage closure with
51. Srivastava MC, See VY, Dawood MY, Price MJ. A review of the Watchman Device in patients with atrial fibrillation:
the LARIAT device: Insights from the cumulative clinical A PROTECT AF (percutaneous closure of the left atrial
experience. Springerplus. 2015;4:522. appendage versus warfarin therapy for prevention of stroke
doi: 10.1186/s40064-015-1289-8 in patients with atrial fibrillation) substudy. J Am Coll
Cardiol. 2012;59:923-929.
52. Sommer RJ, Kim JH, Szerlip M, et al. Conformal left atrial
appendage seal device for left atrial appendage closure. J Am doi: 10.1016/j.jacc.2011.11.028
Coll Cardiol Interv. 2021;14:2368-2374.
62. Afzal MR, Gabriels JK, Jackson GG, et al. Temporal changes
doi: 10.1016/j.jcin.2021.08.060 and clinical implications of delayed peridevice leak following
53. Asmarats L, Rodés-Cabau J. Percutaneous left atrial left atrial appendage closure. JACC Clin Electrophysiol.
appendage closure: Current devices and clinical outcomes. 2022;8:15-25.
Circ Cardiovasc Interv. 2017;10(11):e005359. doi: 10.1016/j.jacep.2021.06.018
doi: 10.1161/CIRCINTERVENTIONS.117.005359 63. Korsholm K, Jensen JM, Norgaard BL, et al. Peridevice leak
54. Russo G, Taramasso M, Maisano F. Transseptal following amplatzer left atrial appendage occlusion: Cardiac
puncture: Procedural guidance, challenging situations computed tomography classification and clinical outcomes.
and management of complications. EuroIntervention. J Am Coll Cardiol Interv. 2021;14:83-93.
2021;17(9):720-727. doi: 10.1016/j.jcin.2020.10.034
doi: 10.4244/EIJ-D-20-00454 64. Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left
55. Kataria V, Berte B, Vandekerckhove Y, Tavernier R, atrial appendage closure: From the PREVAIL and PROTECT
Duytschaever M. Modified transseptal puncture technique AF trials. J Am Coll Cardiol. 2017;70(24):2964-2975.

Volume 3 Issue 3 (2025) 11 doi: 10.36922/bh.4016